News
TSH Biopharm was invited to attend the institutional investor conference hosted by Concord Securities
2023.9.6
...
More
TSH Board of Directors Approved Financial Statements For the Six Months Ended June 30, 2023
2023.8.14
...
More
Expand New Therapeutic Area in Chronic Disease, TSH Entering Ophthalmic Market
2023.7.13
...
More
TSH Board of Directors resolved to convene the 2023 Annual General Shareholders' Meeting
2023.2.24
...
More
TSH Biopharm was invited to attend the institutional investor conference hosted by Concord Securities
2023.3.7
...
More
To announce newly recommended Chairman
2023.5.25
...
More